longbridge

BETTA PHARMACEUTICALS

300558
----

All Shareholders

Shareholder Type

  • Public and others41.67%
  • Private companies27.94%
  • Institutions15.28%
  • VC/PE firms12.83%
  • Individuals & Insiders2.28%

Major Shareholders

Major Shareholders Latest
Shareholder
Ningbo Kaiming Investment Management Partnership Enterprise (Limited Partnership)
18.91%80.06M0.12%+0
Zhejiang Jihe Venture Capital Co., Ltd.
12.83%54.32M0.08%+0
Hangzhou Terui Xichuang Enterprise Management Partnership Enterprise (Limited Partnership)
6.69%28.30M0.16%-495.90K
AEGON-Industrial Fund Management Co. Ltd.
3.75%15.88M0.02%+0
Zhejiang Beicheng Investment Management Partnership (Limited Partnership)
2.34%9.92M0.01%+0
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
1.27%5.36M<0.01%+0
E Fund Management Co., Ltd.
1.15%4.86M<0.01%+0
New China Life Insurance Company Ltd.
1.08%4.58M<0.01%+0
Zhong Ou Fund Management Co., Ltd
1.03%4.35M<0.01%+0
Hancheng Zhang
0.96%4.08M<0.01%+0
Yinxiang WangFormer President
0.96%4.06M<0.01%+0
China Southern Asset Management Co., Ltd.
0.89%3.75M<0.01%+0
Yinhua Fund Management Co., Ltd.
0.79%3.36M<0.01%+0
GF Fund Management Co., Ltd.
0.79%3.36M<0.01%+0
ICBC Credit Suisse Fund Management Co., Ltd
0.50%2.10M<0.01%+0
Guotai Asset Management Company Limited
0.48%2.01M<0.01%+0
Fullgoal Fund Management Co. Ltd.
0.35%1.50M<0.01%+0
Golden Trust SinoPac Fund Management Co., Ltd.
0.33%1.41M<0.01%+0
China Asset Management Co. Ltd.
0.31%1.31M<0.01%+0
Vanguard Capital Management, LLC
0.28%1.17M0.02%+73.90K
© 2026 Longbridge｜Terms of ServicePrivacy Policy